New hope for kids with MS: experimental drug enters trial

NCT ID NCT07161258

First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 26 times

Summary

This study tests an experimental drug called fenebrutinib in 12 children and teens (ages 10 to under 18) with relapsing multiple sclerosis. The goal is to see how the drug works in the body, whether it reduces brain lesions, and if it is safe. Participants can choose to continue the drug in an extension period after the main study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centro Clnico Acadmico - Braga, Associao (2CA-Braga)

    RECRUITING

    Braga, 4710-243, Portugal

  • Centro de Pesquisas Clinicas - CPCLIN

    RECRUITING

    São Paulo, São Paulo, 01228-200, Brazil

  • Clinstile S.A de C.V.

    RECRUITING

    Mexico City, Mexico CITY (federal District), 06700, Mexico

  • Hospital Universitario Ramon y Cajal

    RECRUITING

    Madrid, 28034, Spain

  • Hospital Universitario Virgen Macarena

    RECRUITING

    Seville, 41009, Spain

  • Hospital Universitario de La Princesa

    RECRUITING

    Madrid, 28006, Spain

  • INECO Neurociencias Orono

    RECRUITING

    Rosario, Santa Fe Province, S2000DTB, Argentina

  • Instituto de Neurologia de Curitiba - Hospital Ecoville

    RECRUITING

    Curitiba, Paraná, 81210-310, Brazil

  • Instytut "Pomnik - Centrum Zdrowia Dziecka"

    RECRUITING

    Warsaw, 04-730, Poland

  • L2IP ?Instituto de Pesquisas Clínicas Ltda.

    RECRUITING

    Brasília, Federal District, 70200-730, Brazil

  • Neurociencias Estudios Clinicos S.C.

    RECRUITING

    Culiacán, Sinaloa, 80020, Mexico

  • Nucleo de Pesquisa Clinica do Rio Grande do Sul NPCR

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90430-001, Brazil

  • Sanatorio del Sur S.A.

    RECRUITING

    San Miguel de Tucumán, T4000IDK, Argentina

  • UH of State NPC Danulo Halytsky NMU in Lviv CID, Clinic of Neurology and Neurosurgery

    RECRUITING

    Lviv, 79010, Ukraine

  • Unidade Local de Saude de Coimbra E P E

    RECRUITING

    Coimbra, 3000-602, Portugal

  • Uniwersytecki Szpital Kliniczny w Poznaniu

    RECRUITING

    Poznan, 60-355, Poland

  • Uniwersyteckie Centrum Kliniczne

    RECRUITING

    Gdansk, 80 952, Poland

Conditions

Explore the condition pages connected to this study.